Zobrazeno 1 - 10
of 651
pro vyhledávání: '"Hepatitis A antibody"'
Autor:
Jin Gu Kang, Myoung Kuk Jang, Jung Hee Kim, Jang Han Jung, Ji Won Park, Sung Eun Kim, Sang Hoon Park, Myung Seok Lee, Ki Tae Suk, Dong Joon Kim, Hyoung Su Kim
Publikováno v:
The Korean Journal of Internal Medicine, Vol 38, Iss 3, Pp 362-371 (2023)
Background/Aims Although anti-hepatitis C virus (HCV) assay is widely used to screen for HCV infection, it has a high false-positive (FP) rate in low-risk populations. We investigated the accuracy of anti-HCV signal-to-cutoff (S/CO) ratio to distingu
Externí odkaz:
https://doaj.org/article/42eaf79331a84b0099993400cc9e578b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mehrzad Kaviani, Javad Kia
Publikováno v:
International Journal of Scientific Research in Dental and Medical Sciences, Vol 1, Iss 3, Pp 40-47 (2019)
Background and aim: As Hepatitis B is a viral infectious disease that transmits through blood, the purpose of this study was to evaluate the antibody titration against hepatitis B and its related factors in dental students in Guilan University of Med
Externí odkaz:
https://doaj.org/article/00f5c8bd09634abdbd30c2b7d77f87ed
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hua-Ping Huang, Guo-Sheng Yuan, Yu-Chen Zhou, Cheng-Guang Hu, Jun-Wei Liu, Shuai Yuan, Yu-Rong Qiu, Yi-Ping Li, Yong-Yuan Zhang, Yuan-Ping Zhou
Publikováno v:
Asian Pacific Journal of Tropical Medicine, Vol 11, Iss 2, Pp 171-176 (2018)
Objective: To determine the frequency of anti-HCV antibody positivity in patients with non-liver disease complaints, to explore whether anti-HCV positive patients had been properly advised and visited hepatologists for further assessments, and to inv
Externí odkaz:
https://doaj.org/article/65402a44e7e745b38a5a211d720b465d
Autor:
Ann Winters, Nadine Kela-Murphy, Emily Harrison, Marie P. Bresnahan, Charu M. Verma, Miranda S. Moore, Jessie Schwartz
Publikováno v:
Journal of Public Health Management and Practice. 28:E413-E420
CONTEXT As of 2015, an estimated 116000 New York City (NYC) residents had chronic hepatitis C, many of them undiagnosed. Although effective medications have been available since 2014 with the advent of direct-acting antivirals, provider-based barrier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01ca281208d0ceb733ec58160d7d95f8
https://doi.org/10.1097/phh.0000000000001402
https://doi.org/10.1097/phh.0000000000001402
Autor:
Wesley Durkalski, Robert D. Allison, Naomi Tamez, John R. Litaker, Richard P. Taylor, Carlos Lopez Bray
Publikováno v:
Population Health Management
Infection with the hepatitis C virus (HCV) is the most commonly reported bloodborne infection in the United States. Individuals born between 1945–1965, the baby boomers, account for approximately 75% of all chronic HCV infections in the United Stat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebce36b5587bbdb625cfe4cd271d18f9
https://doi.org/10.1089/pop.2020.0214
https://doi.org/10.1089/pop.2020.0214
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mandana Rafeey, Maryam Shoaran
Publikováno v:
Journal of Analytical Research in Clinical Medicine, Vol 2, Iss 4, Pp 183-186 (2014)
Introduction: Hepatitis A is the most common viral hepatitis during childhood especially in developing countries. It is, usually, self-limiting, but may be associated with severe complications in some patients particularly those with comorbidities.
Externí odkaz:
https://doaj.org/article/5979ad913b8f4acabd0311393334b6f2
Publikováno v:
Harm Reduction Journal, Vol 18, Iss 1, Pp 1-6 (2021)
Harm Reduction Journal
Harm Reduction Journal
Background Between December 2018 and January of 2019, we evaluated the accuracy of the point-of-care Hepatitis C (HCV) antibody test (POC; OraQuick HCV) used at a community-based needle and syringe exchange program serving persons who inject drugs in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::245a87586336730d191986bb0f74a03e
https://doaj.org/article/4fb6e6368f624cabb59743898fb54824
https://doaj.org/article/4fb6e6368f624cabb59743898fb54824